首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Involvement of miRNA-29a in epigenetic regulation of transforming growth factor-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma
【24h】

Involvement of miRNA-29a in epigenetic regulation of transforming growth factor-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma

机译:miRNA-29a参与肝细胞癌转化生长因子-β诱导的上皮-间质转化的表观遗传调控

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: Epithelial-mesenchymal transition (EMT) is a crucial process during cancer invasion and metastasis, which is accompanied by the suppressed expression of E-cadherin initiated by stimuli such as transforming growth factor (TGF)-β. Recent studies have shown that the epigenetic regulation of E-cadherin could be an alternate mechanism of EMT induction in hepatocellular carcinoma (HCC). miRNA-29a (miR-29a) is involved in the epigenetic regulation of genes by targeting DNA methyltransferases (DNMT), which methylate CpG islands to suppress the transcription of genes. We studied the involvement of miR-29a in TGF-β-induced EMT in HCC cells. Methods: We treated human HCC cell lines with TGF-β to induce EMT. To investigate DNA methylation in EMT, cells were treated with a methylation inhibitor, 5-Aza-2′-deoxycytidine (5-Aza) and methylation status of CpG islands in the E-cadherin promoter was examined using methylation-specific PCR. Precursor miR-29a (pre-miR-29a) was electroporated to force the expression of miR-29a in HCC cells in order to study the role of miR-29a in EMT. Results: TGF-β transformed HCC cells into a spindle-shaped morphology accompanied by a decrease of E-cadherin with the induction of methylation of its promoter. Pretreatment of the cells with 5-Aza blocked this suppression of E-cadherin, indicating the involvement of DNA methylation. TGF-β increased DNMT3B and DNMT1 and decreased miR-29a expression. The forced expression of miR-29a abrogated the suppression of E-cadherin induced by TGF-β. Conclusion: miR-29a could regulate TGF-β-induced EMT by affecting DNA methylation via the suppression of DNMT. These observations reveal the epigenetic regulation of genes by miRNA as a unique mechanism of EMT in HCC.
机译:目的:上皮-间质转化(EMT)是癌症侵袭和转移过程中的关键过程,伴随着由转化生长因子(TGF)-β等刺激引发的E-钙粘蛋白表达受到抑制。最近的研究表明,E-钙粘蛋白的表观遗传调控可能是肝细胞癌(HCC)中EMT诱导的另一种机制。 miRNA-29a(miR-29a)通过靶向DNA甲基转移酶(DNMT)参与基因的表观遗传调控,该DNA甲基化CpG岛以抑制基因的转录。我们研究了miR-29a在TGF-β诱导的HCC细胞EMT中的参与。方法:我们用TGF-β处理人HCC细胞系以诱导EMT。为了研究EMT中的DNA甲基化,用甲基化抑制剂5-Aza-2'-脱氧胞苷(5-Aza)处理细胞,并使用甲基化特异性PCR检测E-钙粘蛋白启动子中CpG岛的甲基化状态。为了研究miR-29a在EMT中的作用,对前体miR-29a(pre-miR-29a)进行了电穿孔,以使其在HCC细胞中表达。结果:TGF-β将HCC细胞转化为纺锤形形态,伴随着E-钙黏着蛋白的减少和启动子甲基化的诱导。用5-Aza预处理细胞可阻止E-钙粘蛋白的这种抑制,表明DNA甲基化的参与。 TGF-β增加DNMT3B和DNMT1并降低miR-29a表达。 miR-29a的强制表达消除了TGF-β诱导的E-钙黏着蛋白的抑制。结论:miR-29a可以通过抑制DNMT来影响TGF-β诱导的EMT,从而影响DNA甲基化。这些发现揭示了miRNA对基因的表观遗传调控,这是HCC中EMT的独特机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号